The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 421.10
Bid: 420.00
Ask: 420.10
Change: 15.40 (3.80%)
Spread: 0.10 (0.024%)
Open: 411.70
High: 421.10
Low: 409.20
Prev. Close: 405.70
RR. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement and Trading Update

11 May 2023 07:00

RNS Number : 0147Z
Rolls-Royce Holdings plc
11 May 2023
 

11 May 2023

 

ROLLS-ROYCE HOLDINGS PLC AGM STATEMENT AND TRADING UPDATE

 

Rolls-Royce Holdings plc is holding its Annual General Meeting today. In his address to shareholders, Chief Executive Tufan Erginbilgic will comment:

"We are transforming Rolls-Royce into a high quality and competitive business with a strong balance sheet and growing profit, cash flows and returns. We are already benefitting from the actions we are taking as well as recovery and growth in our end markets. We announced several changes to the executive team in March to support the transformation, adding leaders with proven track records of delivery and high-performance. We are making good progress and our financial performance year-to-date is in line with expectations. I'd like to thank everyone at Rolls-Royce for their hard work and commitment so far. I am confident that, together, we can achieve great results."

 

Trading update to 30 April 2023

Our financial performance is improving reflecting positive changes driven by our transformation programme workstreams and good end market demand for our products and services. Supply chain management remains a key operational challenge for us as original equipment and aftermarket services volumes increase, especially in Civil Aerospace. Our financial performance is in line with our expectations at the time of the full year results on 23 February. Our underlying operating profit guidance of £0.8-£1.0bn and free cash flow guidance of £0.6-£0.8bn in 2023 is unchanged. We anticipate our free cash flow generation will be seasonally weighted in the second half of the year, as previously indicated.

 

In Civil Aerospace, long term service agreement large engine flying hours (EFH) were 83% of 2019 levels in the four months to 30 April, and on track for the 80% to 90% range for the full year, as guided in February. Shop visit volumes and OE deliveries are also on track with expectations. We have continued to win new business including our biggest ever order of Trent XWB-97 engines in the period, with an MoU for 68 engines (plus 20 options) for Air India.

 

In Defence, we continued our successful run of key programme awards with the announcement that the AUKUS submarine programme will be powered by Rolls-Royce nuclear reactors. In the US, Bell's V-280 Valor, powered by our AE1107F engines, cleared the protest period, enabling our teams to progress to the next phase, with the first aircraft due to enter into service in 2030. Bell's V-280 Valor was selected last year by the US Army's Future Long Range Assault Aircraft programme to replace its Black Hawk helicopters.

 

In Power Systems, revenue growth is being driven by demand for aftermarket services and exceptionally high order intake in the prior year, especially for power generation solutions. We are getting improved pricing on new orders which will drive margins up with the benefits expected to start showing in the second half of the year. High order intake year-to-date included strong demand from marine customers, including an order for Series 4000 gensets for the U.S Navy's Constellation Class frigate programme.

 

Work on the transformation programme is moving at pace. Our increased focus on efficiency and simplification is helping to keep costs down and has already identified savings, for example the closure of our R2 Factory venture. We are encouraged by the early progress of our commercial optimisation and working capital workstreams, with positive results expected to build as the year goes on. Our strategic review is on track and as previously indicated, we will communicate the findings and medium term targets in the second half of 2023.

 

Our Half Year 2023 results will be announced on 3 August 2023.

 

 

For further information, please contact:

 

Media

Richard Wray

Director of External Communications & Brand, Rolls-Royce plc

Tel +44 (0) 7810 850055

Richard.Wray@Rolls-Royce.com

 

 

Investors

Isabel Green

Head of Investor Relations, Rolls-Royce plc

Tel +44 (0) 7880 160976

Isabel.Green@Rolls-Royce.com

www.Rolls-Royce.com

 

About Rolls-Royce Holdings plc

 

About Rolls-Royce Holdings plc

1. Rolls-Royce develops and delivers complex power and propulsion solutions for safety-critical applications in the air, at sea and on land. Our products and service packages enable our customers to connect people, societies, cultures and economies together; they meet the growing need for power generation across multiple industries; and enable governments to equip their armed forces with the power required to protect their citizens.

2. Rolls-Royce has customers in more than 150 countries, comprising more than 400 airlines and leasing customers, 160 armed forces and navies, and more than 5,000 power and nuclear customers. We are committed to making our products compatible with net zero carbon emissions to meet customer demand for more sustainable solutions.

3. The annual underlying revenue was £12.69 billion in 2022, and the underlying operating profit was £652m.

4. Rolls-Royce Holdings plc is a publicly traded company (LSE: RR., ADR: RYCEY, LEI: 213800EC7997ZBLZJH69)

www.rolls-royce.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMNKKBDOBKDCPD
Date   Source Headline
26th Apr 20241:36 pmRNSDirector/PDMR Shareholding
10th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20241:50 pmRNSHolding(s) in Company
2nd Apr 202410:00 amRNSDirector/PDMR Shareholding
26th Mar 202411:00 amRNSDirector/PDMR Shareholding
13th Mar 20249:00 amRNSDirector/PDMR Shareholding
8th Mar 20241:45 pmRNSDirector/PDMR Shareholding
6th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 202411:30 amRNSDirector/PDMR Shareholding
29th Feb 20249:00 amRNSAGM Statement
28th Feb 20243:30 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:30 amRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSFull Year Results 2023
8th Feb 20244:00 pmRNSDirector/PDMR Shareholding
26th Jan 20243:00 pmRNSDirector/PDMR Shareholding
10th Jan 202411:45 amRNSDirector/PDMR Shareholding
21st Dec 20232:00 pmRNSDirector/PDMR Shareholding
21st Dec 20231:58 pmRNSDirector/PDMR Shareholding
20th Dec 202310:00 amRNSHolding(s) in Company
11th Dec 20233:45 pmRNSHolding(s) in Company
8th Dec 202312:00 pmRNSDirector/PDMR Shareholding
1st Dec 20234:00 pmRNSTotal Voting Rights
1st Dec 20233:50 pmRNSDirector/PDMR Shareholding
1st Dec 20233:45 pmRNSDirector/PDMR Shareholding
29th Nov 20232:15 pmRNSDirector/PDMR Shareholding
29th Nov 20231:00 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSCapital Markets Day
8th Nov 202311:30 amRNSDirector/PDMR Shareholding
30th Oct 202310:15 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSRolls-Royce creates more efficient organisation
11th Oct 20232:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20239:30 amRNSHolding(s) in Company
28th Sep 202310:30 amRNSDirector/PDMR Shareholding
11th Sep 20239:30 amRNSDirector/PDMR Shareholding
25th Aug 20232:45 pmRNSDirector/PDMR Shareholding
8th Aug 202312:30 pmRNSDirector/PDMR Shareholding
8th Aug 20239:45 amRNSDirector/PDMR Shareholding
4th Aug 202311:51 amRNSHolding(s) in Company
3rd Aug 20237:00 amRNS2023 Half Year Results
2nd Aug 20237:00 amRNSDirectorate Change
31st Jul 20239:30 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
20th Jul 20239:00 amRNSDirectorate Change
10th Jul 20233:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:32 amRNSTotal Voting Rights
28th Jun 20233:30 pmRNSDirector/PDMR Shareholding
27th Jun 202312:00 pmRNSAdmission of Shares
8th Jun 20232:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
19th May 202312:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.